Precision BioSciences Inc (DTIL) — Cash Flow-to-Debt Ratio
Precision BioSciences Inc (DTIL) has a Cash Flow-to-Debt Ratio of -0.17x as of June 2026, meaning its operating cash flow of $-13.44 Million could theoretically repay 0% of its total liabilities ($80.63 Million) in one year. See Precision BioSciences Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Precision BioSciences Inc Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Precision BioSciences Inc across 10 annual periods. For the full cash flow conversion analysis, see DTIL cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Precision BioSciences Inc (2016–2025)
Year-by-year debt coverage analysis for Precision BioSciences Inc. Check Precision BioSciences Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.06x | $-65.84 Million | $62.17 Million | ▼ -45.0% |
| 2024 | -0.73x | $-58.45 Million | $80.00 Million | ▼ -22.4% |
| 2023 | -0.60x | $-84.11 Million | $140.92 Million | ▼ -131.9% |
| 2022 | -0.26x | $-45.75 Million | $177.74 Million | ▼ -185.4% |
| 2021 | -0.09x | $-10.85 Million | $120.33 Million | ▲ +89.1% |
| 2020 | -0.83x | $-87.39 Million | $105.73 Million | ▼ -8.8% |
| 2019 | -0.76x | $-73.64 Million | $96.92 Million | ▼ -44.9% |
| 2018 | -0.52x | $-51.72 Million | $98.64 Million | ▼ -114.9% |
| 2017 | -0.24x | $-24.17 Million | $99.05 Million | ▼ -127.3% |
| 2016 | 0.89x | $92.27 Million | $103.16 Million | — |